A Phase 2, Randomized, Placebo-Controlled, Double-Masked, Multicenter Safety and Efficacy Study of C-KAD Ophthalmic Solution in Patients With Loss of Visual Acuity Due to Age-Related Cataract
A Phase 2, Randomized, Placebo-Controlled, Double-Masked, Multicenter Safety and Efficacy Study of C-KAD Ophthalmic Solution in Patients With Loss of Visual Acuity Due to Age-Related Cataract
The purpose of this study is to determine the safety and efficacy of C-KAD Ophthalmic Solution in improving visual acuity relative to placebo in patients with age-related cataract
Inclusion Criteria:
Exclusion Criteria:
San Francisco, California 94115, United States
leslie@pacificeyespecialists.com650-726-1500
mjones@hunkeler.com913-338-4733
research@mneye.com612-813-3607
mwalker@ceenta.com704-295-3386